S&P 500
5.022,21 -29,20 (-0,58%) Nasdaq
15.683,37 -181,88 (-1,15%) NIKKEI 225
38.090,87 +129,07 (+0,34%) Dólar/Euro
1,0678 +0,0003 (+0,03%) Petróleo Brent
87,55 +0,26 (+0,30%) Bitcoin EUR
58.123,69 -1.840,62 (-3,07%)
Microbot Medical Inc. (MBOT)
Después del cierre:
Microbot Medical Inc.
288 Grove Street
Suite 388
Braintree, MA 02184
United States
781 875 3605
https://www.microbotmedical.com
Sector(es): Healthcare
Sector: Medical Instruments & Supplies
Empleados a tiempo completo: 21
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Harel Gadot | Co-Founder, President, CEO & Chairman | 813,82k | N/A | 1973 |
| Mr. Yoseph Bornstein | Co-Founder & Independent Director | 13,12k | N/A | 1959 |
| Ms. Rachel Vaknin | Chief Financial Officer | 212,97k | N/A | 1980 |
| Dr. Simon Sharon MBA, MSc | CTO & GM of Microbot Israel | 381,51k | N/A | 1961 |
| Dr. Juan Diaz-Cartelle | Chief Medical Officer | N/A | N/A | 1976 |
Descripción
Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. In addition, it provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
Gobierno corporativo
El ISS Governance QualityScore de Microbot Medical Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
